Insider · CIK 0001277478

SBLENDORIO GLENN

Reports to the SEC for 7 companies · EMERYVILLE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001277478

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-17	FDMT4D Molecular Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2026-04-27	AMICUS THERAPEUTICS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−143K sh	$14.50	−$2.07M	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16.2K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−19.5K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18.6K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−36.1K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−45.4K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30.5K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−42.5K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−74.9K sh	—	—	0
2026-02-19	MLYSMineralys Therapeutics, Inc.A Award	Director	AAward	+6,200 sh	—	—	6,200
2026-02-19	MLYSMineralys Therapeutics, Inc. · Stock OptionA Award	Director	AAward	+8,300 sh	—	—	8,300
2026-01-05	FDMT4D Molecular Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+45K sh	—	—	45,000
2025-06-05	AMICUS THERAPEUTICS, INC.A Award	Director	AAward	+20.4K sh	—	—	115,857
2025-06-05	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)A Award	Director	AAward	+74.9K sh	—	—	74,872
2025-02-13	MLYSMineralys Therapeutics, Inc. · Stock OptionA Award	Director	AAward	+32.9K sh	—	—	32,900
2024-06-06	AMICUS THERAPEUTICS, INC.A Award	Director	AAward	+11.8K sh	—	—	95,443
2024-06-06	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)A Award	Director	AAward	+42.5K sh	—	—	42,467
2024-05-22	MLYSMineralys Therapeutics, Inc. · Stock OptionA Award	Director	AAward	+22K sh	—	—	22,000
2024-03-07	AMICUS THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$2.80	+$42K	83,596
2024-03-07	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.U Disposition from Tender	Director	UDisposition from Tender	−23.4K sh	$19.00	−$445K	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−8,111 sh	$19.00	−$154K	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−12.1K sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−12.8K sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−551 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−1,750 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−1,598 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−2,036 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−2,748 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−2,174 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−2,966 sh	—	—	0
2023-09-13	MLYSMineralys Therapeutics, Inc. · Stock OptionA Award	Director	AAward	+44K sh	—	—	44,000
2023-07-11	IVERIC bio, Inc.D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−239K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Restricted Stock UnitsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−23.8K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Restricted Stock UnitsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−73.3K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Restricted Stock UnitsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−94.5K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Restricted Stock UnitsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−150K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−6,949 sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−15K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−7,000 sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−150K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−260K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−325K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−134K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−190K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−293K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−252K sh	—	—	0

Recent filings

Accepted (ET)
Jun 184
SBLENDORIO GLENN0001193125-26-276144
SEC(opens sec.gov)
Apr 274
SBLENDORIO GLENN0001193125-26-182278
SEC(opens sec.gov)
Feb 204
SBLENDORIO GLENN0001933414-26-000044
SEC(opens sec.gov)
Jan 74
SBLENDORIO GLENN0001193125-26-006809
SEC(opens sec.gov)
Jun 64
SBLENDORIO GLENN0000950170-25-083220
SEC(opens sec.gov)
Feb 244
SBLENDORIO GLENN0001933414-25-000012
SEC(opens sec.gov)
Jun 74
SBLENDORIO GLENN0000950170-24-071004
SEC(opens sec.gov)
May 234
SBLENDORIO GLENN0001933414-24-000022
SEC(opens sec.gov)

Companies

Address

C/O 4D MOLECULAR THERAPEUTICS, INC. 5858 HORTON STREET #455

EMERYVILLE, CA, 94608